These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 10882081)

  • 1. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination.
    Sheaff RJ; Singer JD; Swanger J; Smitherman M; Roberts JM; Clurman BE
    Mol Cell; 2000 Feb; 5(2):403-10. PubMed ID: 10882081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. To be or not to be ubiquitinated?
    Bloom J; Pagano M
    Cell Cycle; 2004 Feb; 3(2):138-40. PubMed ID: 14712075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.
    Diehl JA; Zindy F; Sherr CJ
    Genes Dev; 1997 Apr; 11(8):957-72. PubMed ID: 9136925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 Jul; 18(30):4313-25. PubMed ID: 10439039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation.
    Clurman BE; Sheaff RJ; Thress K; Groudine M; Roberts JM
    Genes Dev; 1996 Aug; 10(16):1979-90. PubMed ID: 8769642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of p21cip1 in cells productively infected with human cytomegalovirus.
    Chen Z; Knutson E; Kurosky A; Albrecht T
    J Virol; 2001 Apr; 75(8):3613-25. PubMed ID: 11264351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo ubiquitination and proteasome-mediated degradation of p53(1).
    Maki CG; Huibregtse JM; Howley PM
    Cancer Res; 1996 Jun; 56(11):2649-54. PubMed ID: 8653711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21.
    Cayrol C; Ducommun B
    Oncogene; 1998 Nov; 17(19):2437-44. PubMed ID: 9824154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras promotes p21(Waf1/Cip1) protein stability via a cyclin D1-imposed block in proteasome-mediated degradation.
    Coleman ML; Marshall CJ; Olson MF
    EMBO J; 2003 May; 22(9):2036-46. PubMed ID: 12727871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway.
    Patrick GN; Zhou P; Kwon YT; Howley PM; Tsai LH
    J Biol Chem; 1998 Sep; 273(37):24057-64. PubMed ID: 9727024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct proteasome inhibition by clasto-lactacystin beta-lactone permits the detection of ubiquitinated p21(waf1) in ML-1 cells.
    Fukuchi K; Maruyama H; Takagi Y; Gomi K
    Biochim Biophys Acta; 1999 Aug; 1451(1):206-10. PubMed ID: 10446402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasome.
    Kiernan RE; Emiliani S; Nakayama K; Castro A; Labbé JC; Lorca T; Nakayama Ki K; Benkirane M
    Mol Cell Biol; 2001 Dec; 21(23):7956-70. PubMed ID: 11689688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome.
    Coulombe P; Rodier G; Bonneil E; Thibault P; Meloche S
    Mol Cell Biol; 2004 Jul; 24(14):6140-50. PubMed ID: 15226418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell attachment to the extracellular matrix induces proteasomal degradation of p21(CIP1) via Cdc42/Rac1 signaling.
    Bao W; Thullberg M; Zhang H; Onischenko A; Strömblad S
    Mol Cell Biol; 2002 Jul; 22(13):4587-97. PubMed ID: 12052868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cyclin C protein is stabilized by its associated kinase cdk8, independently of its catalytic activity.
    Barette C; Jariel-Encontre I; Piechaczyk M; Piette J
    Oncogene; 2001 Feb; 20(5):551-62. PubMed ID: 11313987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kip1 degradation via the ubiquitin-proteasome pathway.
    Tam SW; Theodoras AM; Pagano M
    Leukemia; 1997 Apr; 11 Suppl 3():363-6. PubMed ID: 9209391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDM2 is a negative regulator of p21WAF1/CIP1, independent of p53.
    Zhang Z; Wang H; Li M; Agrawal S; Chen X; Zhang R
    J Biol Chem; 2004 Apr; 279(16):16000-6. PubMed ID: 14761977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.
    Pagano M; Tam SW; Theodoras AM; Beer-Romero P; Del Sal G; Chau V; Yew PR; Draetta GF; Rolfe M
    Science; 1995 Aug; 269(5224):682-5. PubMed ID: 7624798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin-dependent kinase and Cks/Suc1 interact with the proteasome in yeast to control proteolysis of M-phase targets.
    Kaiser P; Moncollin V; Clarke DJ; Watson MH; Bertolaet BL; Reed SI; Bailly E
    Genes Dev; 1999 May; 13(9):1190-202. PubMed ID: 10323869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.